Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
Ironwood Pharmaceuticals (Nasdaq: IRWD) has announced its upcoming fourth quarter and full year 2024 investor update conference call and webcast, scheduled for Thursday, February 27, 2025, at 8:30 a.m. Eastern Time.
Participants can join via phone by dialing (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID 2530602. The webcast will be accessible through the Investors section of Ironwood's website.
A replay will be available from approximately 11:30 a.m. Eastern Time on February 27 until 11:59 p.m. Eastern Time on March 13, 2025. Replay access numbers are (800) 770-2030 (U.S. and Canada) or (609) 800-9909 (international). The webcast recording will remain available on the company's website for one year after the call.
Ironwood Pharmaceuticals (Nasdaq: IRWD) ha annunciato la sua prossima conferenza telefonica e webcast per l'aggiornamento degli investitori relativa al quarto trimestre e all'intero anno 2024, programmata per giovedì 27 febbraio 2025, alle 8:30 ora orientale.
I partecipanti possono unirsi tramite telefono componendo (888) 596-4144 (Stati Uniti e Canada) o (646) 968-2525 (internazionale) utilizzando l'ID conferenza 2530602. Il webcast sarà accessibile attraverso la sezione Investitori del sito web di Ironwood.
Una registrazione sarà disponibile dalle 11:30 ora orientale del 27 febbraio fino alle 23:59 ora orientale del 13 marzo 2025. I numeri per accedere alla registrazione sono (800) 770-2030 (Stati Uniti e Canada) o (609) 800-9909 (internazionale). La registrazione del webcast rimarrà disponibile sul sito dell'azienda per un anno dopo la chiamata.
Ironwood Pharmaceuticals (Nasdaq: IRWD) ha anunciado su próxima conferencia telefónica y webcast de actualización para inversores del cuarto trimestre y del año completo 2024, programada para jueves 27 de febrero de 2025, a las 8:30 a.m. hora del este.
Los participantes pueden unirse por teléfono marcando (888) 596-4144 (EE. UU. y Canadá) o (646) 968-2525 (internacional) utilizando el ID de conferencia 2530602. El webcast será accesible a través de la sección de Inversores en el sitio web de Ironwood.
Una repetición estará disponible desde aproximadamente las 11:30 a.m. hora del este del 27 de febrero hasta las 11:59 p.m. hora del este del 13 de marzo de 2025. Los números de acceso a la repetición son (800) 770-2030 (EE. UU. y Canadá) o (609) 800-9909 (internacional). La grabación del webcast permanecerá disponible en el sitio web de la empresa durante un año después de la llamada.
아이언우드 제약 (Nasdaq: IRWD)은 2024년 4분기 및 연간 투자자 업데이트 컨퍼런스 콜 및 웹캐스트를 2025년 2월 27일 목요일 오전 8시 30분 (동부 표준시)에 개최한다고 발표했습니다.
참가자는 (888) 596-4144 (미국 및 캐나다) 또는 (646) 968-2525 (국제)로 전화하여 2530602 회의 ID를 사용하여 참여할 수 있습니다. 웹캐스트는 아이언우드 웹사이트의 투자자 섹션을 통해 접근할 수 있습니다.
재생은 2월 27일 오전 11시 30분부터 2025년 3월 13일 오후 11시 59분까지 가능하며, 재생 접근 번호는 (800) 770-2030 (미국 및 캐나다) 또는 (609) 800-9909 (국제)입니다. 웹캐스트 녹화는 통화 후 1년 동안 회사 웹사이트에서 제공됩니다.
Ironwood Pharmaceuticals (Nasdaq: IRWD) a annoncé sa prochaine conférence téléphonique et webcast pour la mise à jour des investisseurs concernant le quatrième trimestre et l'année complète 2024, prévue pour jeudi 27 février 2025, à 8h30, heure de l'Est.
Les participants peuvent se joindre par téléphone en composant (888) 596-4144 (États-Unis et Canada) ou (646) 968-2525 (international) en utilisant l'ID de conférence 2530602. Le webcast sera accessible via la section Investisseurs du site Web d'Ironwood.
Une rediffusion sera disponible à partir d'environ 11h30, heure de l'Est, le 27 février jusqu'à 23h59, heure de l'Est, le 13 mars 2025. Les numéros d'accès à la rediffusion sont (800) 770-2030 (États-Unis et Canada) ou (609) 800-9909 (international). L'enregistrement du webcast restera disponible sur le site de l'entreprise pendant un an après l'appel.
Ironwood Pharmaceuticals (Nasdaq: IRWD) hat seine bevorstehende Telefonkonferenz und Webcast zur Investorenaktualisierung für das vierte Quartal und das gesamte Jahr 2024 angekündigt, die für Donnerstag, den 27. Februar 2025, um 8:30 Uhr Eastern Time geplant ist.
Teilnehmer können sich telefonisch unter (888) 596-4144 (USA und Kanada) oder (646) 968-2525 (international) einwählen und die Konferenz-ID 2530602 verwenden. Der Webcast wird über den Bereich Investoren auf der Website von Ironwood zugänglich sein.
Eine Wiederholung wird von etwa 11:30 Uhr Eastern Time am 27. Februar bis 23:59 Uhr Eastern Time am 13. März 2025 verfügbar sein. Die Zugangsnumer für die Wiederholung sind (800) 770-2030 (USA und Kanada) oder (609) 800-9909 (international). Die Webcast-Aufzeichnung bleibt ein Jahr nach dem Anruf auf der Unternehmenswebsite verfügbar.
- None.
- None.
The call will be available for replay via telephone starting Thursday, February 27, 2025, at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on Thursday, March 13, 2025. To listen to the replay, dial (800) 770-2030 (
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases. Ironwood is advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for short bowel syndrome patients who are dependent on parenteral support. In addition, Ironwood has been a pioneer in the development of LINZESS® (linaclotide), the
Founded in 1998, Ironwood Pharmaceuticals is headquartered in
We routinely post information that may be important to investors on our website at www.ironwoodpharma.com. In addition, follow us on X and on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250213887685/en/
Company contact:
Greg Martini
gmartini@ironwoodpharma.com
Investors:
Precision AQ (formerly Stern Investor Relations)
Stephanie Ascher
stephanie.ascher@precisionaq.com
Source: Ironwood Pharmaceuticals, Inc.
FAQ
When is Ironwood Pharmaceuticals (IRWD) releasing its Q4 and full year 2024 results?
How can investors access IRWD's Q4 2024 earnings call?
How long will IRWD's Q4 2024 earnings call replay be available?
What is the conference ID for IRWD's Q4 2024 earnings call?
